2022 Committees

Program Committees

Advertising and Promotion Conference Planning Committee helps FDLI to provide timely and relevant programming regarding advertising and promotion trends, emerging issues, and policy developments. This conference is typically held in the fall.

  • Lauren Caroline Tadros Potter (Staff Liaison), FDLI
  • Erin Monaco Carducci, Novartis Pharmaceuticals Corporation
  • Virginia Foley, Opus Regulatory, Inc.
  • Mark Gardner, Gardner Law, PLLC
  • Mark Gaydos, Sanofi
  • Bryant Godfrey, Foley Hoag
  • Matthew Hegreness, Covington & Burling LLP
  • Mark Carlisle Levy, Eckert Seamans Cherin & Mellott, LLC
  • Komal Karnik Nigam, Hogan Lovells US
  • Gillian M. Russell, King & Spalding LLP
  • Marc J. Scheineson, Alston & Bird LLP
  • Nathan C. Sheers, Paul Hastings
  • Victoria Tamarkin, Tamarkin Consulting LLC
  • Kyle Thomson, American Medical Association

Annual Conference Planning Committee helps plan and implement FDLI’s Annual Conference, the premier event of the food and drug law community. This conference is typically held in the spring.

  • Laura Brown (Staff Liaison), FDLI
  • Stacy Cline Amin, Morrison and Foerster, LLP
  • Mantej Nimi Chhina, BioMarin Pharmaceutical, Inc.
  • Karen Day, Pfizer, Inc.
  • Jonathan A. Havens, Saul Ewing Arnstein & Lehr LLP
  • Colleen Heisey, Jones Day
  • August Horvath, Foley Hoag LLP
  • Chad A. Landmon, Axinn, Veltrop & Harkrider LLP
  • Eric N. Lindblom, Georgetown University
  • Ravyn R. Miller, Medtronic
  • Meredith Q. Olearchik, Campbell Soup Company (Co-Chair)
  • Beth G. Oliva, Fox Rothschild LLP
  • Megan Olsen, Council for Responsible Nutrition
  • Ann Oxenham, FDA
  • John M. Packman, DLA Piper LLP
  • Veleka Peeples-Dyer, Baker McKenzie
  • Vernessa T. Pollard, McDermott Will & Emery (Co-Chair)
  • Sarah Stec, Johnson & Johnson
  • Deborah Tolomeo, Spark Therapeutics
  • Anne K. Walsh, Hyman, Phelps & McNamara, PC

California Programs Planning Committee helps FDLI identify pertinent topics and develop programming to be offered in California.

  • Khara Minter (Staff Liaison), FDLI
  • Philip George Johnson, IQVIA
  • Vinita Kailasanath, Freshfields Bruckhaus Deringer
  • Abby Meyer, Sheppard Mullin Richter & Hampton LLP
  • Kiera Murphy, Latham & Watkins LLP

Clinical Trials Conference Planning Committee supports FDLI’s implementation of the 2022 Clinical Trials Conference by providing relevant topics and identifying current and evolving issues central to clinical trial development and utilization.

  • Lauren Caroline Tadros Potter, Esq. (Staff Liaison), FDLI
  • Jacqueline Berman, Morgan, Lewis & Bockius LLP
  • Elvira Cawthon, EAS Consulting Group
  • Margo Heath-Chiozzi, Celldex Therapeutics, Inc.
  • Minerva Hughes, FDA
  • John Kendzior, Reed Smith LLP
  • Geoffrey Levitt, DLA Piper LLP  
  • Brian Malkin, McDermott Will & Emery
  • Lance Shea, BakerHostetler
  • Eva Temkin, King & Spalding LLP 
  • Jonathan Walland, Pfizer 
  • Carolina Wirth, Faegre Drinker Biddle & Reath LLP

Enforcement, Litigation, and Compliance Conference Planning Committee helps FDLI cover the latest trends and changes in enforcement and compliance. This conference is typically held in the fall.

  • Laura Brown (Staff Liaison), FDLI
  • Adrienne Franco Busby, Faegre Drinker Biddle & Reath LLP
  • Maya P. Florence, Skadden, Arps, Slate, Meagher & Flom LLP
  • Perham Gorji, FDA – OC
  • William Gould, Holland & Knight LLP
  • Dennis C. Gucciardo, Morgan, Lewis & Bockius LLP
  • Bryan M. Haynes, Troutman Pepper Hamilton Sanders LLP
  • Michael L Keech, IQVIA
  • Winston S. Kirton, BakerHostetler
  • Fred Medick, Genentech, Inc.
  • Anne K. Miller, Medtronic
  • Sonia W. Nath, Cooley LLP
  • Teresa Park, Covington & Burling LLP
  • Bob Rhoades, Validant
  • Allen Sayler, EAS Consulting Group
  • Ami Simunovich, Becton Dickinson & Co. (BD)
  • William Stellmach, Willkie Farr & Gallagher LLP
  • Beth P. Weinman, Ropes & Gray LLP

Food Advertising, Labeling, and Litigation Conference Planning Committee helps FDLI to provide updates on the most pertinent aspects and trends in advertising, labeling, and litigation. This conference is typically held in the fall.

  • Steven Leslie (Staff Liaison), FDLI
  • Matthew G. Ball, K&L Gates LLP
  • Kimberly M. Bousquet, Thompson Coburn LLP
  • Jacqueline J. Chan, Kleinfeld, Kaplan & Becker, LLP
  • Christopher A. Cole, Crowell & Moring LLP
  • Stefanie Fogel, DLA Piper LLP
  • Dale J. Giali, King & Spalding LLP
  • Linda Goldstein, BakerHostetler
  • Jensen Jose, Center for Science in the Public Interest
  • Maia C. Kats, Just Food Law
  • Joanna Pearce, Haynes and Boone LLP
  • Evangelia C. Pelonis, Keller and Heckman LLP
  • Michael R. Reese, Reese, LLP
  • Michael T. Roberts, UCLA School of Law
  • Thomas Tobin, Perkins Coie LLP
  • Christopher Van Gundy, Sheppard Mullin Richter & Hampton LLP
  • Jack Wenik, Epstein Becker & Green, PC

Food and Dietary Supplements Safety and Regulation Conference Planning Committee helps FDLI cover recent developments and looming challenges for product safety and regulation. The conference is typically held in the Spring.

*This committee is not seeking applications for 2022

  • Steve Leslie (Staff Liason), FDLI
  • Steve Armstrong, Haynes and Boone, LLP
  • Ricardo Carvajal, Hyman, Phelps & McNamara, PC
  • Jacqueline J. Chan, Kleinfeld, Kaplan & Becker, LLP
  • Elizabeth Barr Fawell, Hogan Lovells US LLP
  • Andrea G. Ferrenz, Campbell Soup Company
  • Neal Fortin, Michigan State University College of Law
  • Ryan Gooley, Stericycle
  • Karen Jensen, Vitaflo International – A Nestle Health Science Company
  • Elizabeth (Beth) Johnson, Food Directions LLC
  • Jensen Jose, Center for Science in the Public Interest
  • Heili Kim, Faegre Drinker Biddle & Reath LLP
  • Sarah Roller, Kelley Drye & Warren LLP
  • Nury Helena Yoo, Faegre Drinker Biddle & Reath, LLP

New to Food and Drug Law Planning Committee assists FDLI in creating educational programming and networking opportunities for those new to food and drug law.

  • Bianca N. Cardona Melendez (Staff Liaison), FDLI
  • Alexander V. Alfano, Sterne, Kessler, Goldstein & Fox P.L.L.C.
  • Andrea Chamblee, GW University
  • Kathryn Culver, Latham & Watkins LLP
  • Anthony Fanucci, Alston & Bird LLP
  • Harrison Farmer, McDermott Will & Emery
  • Lauren Farruggia, Goodwin Procter LLP
  • Jaclyn Fonteyne, Sidley Austin LLP
  • Andrew Freedman, Hodgson Russ LLP
  • Seth Gitner, Saul Ewing Arnstein & Lehr LLP
  • Coleen Hill, Duane Morris LLP
  • Samantha Hong, Kleinfeld, Kaplan & Becker, LLP
  • Maria Kalousi-Tatum, Morgan, Lewis & Bockius LLP
  • Matthew Piscitelli, DLA Piper LLP (US)
  • Tony Subketkaew, Haynes and Boone LLP
  • Stuart TenHoor, Stuart TenHoor Legal Search

Patient Organization Engagement Committee assists FDLI by creating innovative introductory course offerings for patient organizations.

  • Paige Samson (Staff Liaison), FDLI
  • Mitchell Berger, FDA – CBER
  • Ryan Hohman, Friends of Cancer Research
  • Katherine Maynard, Peterson Wilmarth and Robertson, LLP (PWR)
  • Peter Pitts, Center for Medicine in the Public Interest
  • Jodi Schipper, FDA – OC
  • Deborah Shelton, ACPMP
  • Kathryn Spates, National Institutes of Health
  • James E. Valentine, Hyman, Phelps & McNamara, PC
  • David Zook, Faegre Drinker Biddle & Reath LLP

Webinar Programs Committee advises FDLI in formulating and implementing webinars about law, regulation and policy affecting food and dietary supplements, tobacco and nicotine, and medical products.

  • Khara Minter (Staff Liaison), FDLI
  • Benjamin Abel, McGuireWoods LLP
  • Nathan A. Beaver, Foley & Lardner LLP
  • Hannah Bornstein, Nixon Peabody
  • Reetuparna Dutta, Hodgson Russ LLP
  • Elizabeth A. Gallenagh, Healthcare Distribution Alliance (HDA)
  • Monica Groat, Latham & Watkins LLP
  • Bethany Hills, DLA Piper LLP (US)
  • Christopher M. Mikson, DLA Piper LLP (US)
  • Joshua Oyster, Ropes & Gray LLP
  • Adam Pierson, DLA Piper LLP (US)
  • Lee Rosebush, Baker Hostetler
  • Alyssa Samuel, Husch Blackwell LLP
  • Steven S. Tjoe, Goodwin Procter LLP

Publications Committees

Austern Writing Awards Committee fosters the next generation of professionals in the food and drug law field.

  • Paige Samson (Staff Liaison), FDLI
  • Meryl E Bartlett, Latham & Watkins LLP
  • Sarah Blankstein, Ropes & Gray LLP
  • Kelly Cho, Sidley Austin LLP
  • Madeleine Giaquinto, Greenleaf Health, Inc.
  • Rebecca (Becca) Jones McKnight, Reed Smith LLP (US)
  • Elizabeth Mulkey, Goodwin Procter LLP
  • Melissa Runsten, Debevoise & Plimpton, LLP
  • Mariam Sarwar, Crowell & Moring LLP

Food and Drug Law Journal Editorial Advisory Board provides peer review of manuscript submissions, advises on content, and serves as a resource for our student editors at Georgetown University Law Center.

  • Paige Samson (Staff Liaison), FDLI
  • Daren Bakst, The Heritage Foundation
  • Nathan A. Beaton, Latham & Watkins LLP
  • Laurie J. Beyranevand, Vermont Law School
  • Jennifer Black, FDA – OC
  • Marie Boyd, University of South Carolina
  • Nathan A. Brown, Akin Gump Strauss Hauer & Feld LLP
  • Christine P. Bump, Penn Avenue Law & Policy
  • Jonathan M. Cohen, K&L Gates LLP
  • Bridget C.E. Dooling, George Washington University
  • Tammi Etheridge, Elon University School of Law
  • Jamie W. Gamerman, FDA – CDER
  • Lewis A. Grossman, American University
  • Peter Barton Hutt, Covington & Burling LLP
  • William M. Janssen, Charleston School of Law
  • John F. Johnson III, Shook, Hardy & Bacon LLP
  • Alan C. Katz, toXcel, LLC
  • Sara Koblitz, Hyman Phelps & McNamara
  • Marian J. Lee, Gibson Dunn & Crutcher LLP
  • Erika Lietzan, (Chair) University of Missouri-Columbia School of Law
  • Priya Malavika Mannan, Novartis Pharmaceuticals Corporation
  • Eileen M. McMahon, Torys LLP
  • Cynthia L. Meyer, Kleinfeld, Kaplan & Becker, LLP
  • Alan G. Minsk, Arnall Golden Gregory LLP
  • Adam Muchmore, Penn State Law
  • James O’Reilly, University of Cincinnati
  • Daniel Orr, Thomson Reuters
  • Tina Papagiannopoulos, Foley Hoag LLP
  • Jessica Ringel, King & Spalding LLP
  • Tyler Scandalios, Arnold & Porter LLP
  • Shy Shorer, National Institutes of Health
  • David Simon, Harvard Law School
  • Anna Sims, FDA – OC
  • Eric Solowey, Parexel International Corporation
  • Genevieve M. Spires, Melinta Therapeutics
  • Emily Wright, Pfizer Inc.

Publications and Academic Programs Committee helps identify areas for scholarly programming and provides high-level recommendations for all of FDLI’s publications, including updating essential references and generating content for new book resources.

  • Paige Samson (Staff Liaison), FDLI
  • Barbara A. Binzak Blumenfeld, Buchanan Ingersoll & Rooney PC
  • Dale Cooke, PhillyCooke Consulting
  • Joanne Hawana, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  • Victor Krauthamer, George Washington University
  • Laurie Lenkel, FDA – OC
  • Elizabeth Richards, Latham & Watkins LLP
  • George Serafin, FTI Consulting, Inc.

Publications Peer Review Committee provides manuscript review and editorial feedback for Update magazine, electronic resources, and book chapters.

  • Paige Samson (Staff Liaison), FDLI
  • David Abramowitz, Locke Lord LLP
  • Royce DuBiner, McGuireWoods LLP
  • Rouget Henschel, Potomac Law Group, PLLC
  • Mingham Ji, Covington & Burling LLP
  • Justine E. Lenehan, Kleinfeld, Kaplan & Becker, LLP
  • Peter V. Lindsay, Paul Hastings, LLP
  • Caitlyn Ozier, King & Spalding LLP
  • Jarred L. Reiling, DLA Piper LLP (US)
  • Marc Wagner, BakerHostetler

Product Area Committees

Cannabis-Derived Products Committee assists FDLI with developing content and identifying stakeholders to contribute to the discussion of cannabis-derived products in the federal regulatory space.

  • Steven Leslie (Staff Liaison), FDLI
  • Holly J. Bayne, Law Office of Bayne & Associates
  • Rodney William Butt, Nutrasource Pharmaceutical & Nutraceutical Services
  • Sarah A Chase, Council for Federal Cannabis Regulation (CFCR)
  • Amanda Cowley, U.S. Pharmacopeia
  • Marshall A. Custer, Husch Blackwell LLP
  • Kay Doyle, Jazz Pharmaceuticals
  • William Garvin, Buchanan Ingersoll & Rooney PC
  • Jae Kim, DLA Piper LLP (US)
  • Andrew Kline, Perkins Coie LLP
  • Dan Logan, Kleinfeld, Kaplan & Becker, LLP
  • Deborah Miran, DMiran Consulting
  • Teresa Reguly, Torys LLP
  • Daniel Rubenstein, Steptoe & Johnson LLP
  • Frederick A. Stearns, Keller and Heckman LLP
  • Elizabeth Butterworth Stutts, Elizabeth Butterworth Stutts, Esq, PLLC

Medical Products Committee helps FDLI provide programming to meet the needs of the medical products community.

  • Laura Brown (Staff Liaison), FDLI
  • Kalah Auchincloss, Greenleaf Health, Inc.
  • Bryan J. Coleman, EAS Consulting Group
  • Delia Ann Deschaine, Epstein Becker & Green, PC
  • Ernest Fung, Cardno ChemRisk
  • Kelly Goldberg, PhRMA
  • Elizabeth Guo, FDA – OC
  • Margo Heath-Chiozzi, Celldex Therapeutics, Inc.
  • Mark Hendrickson, Leavitt Partners, LLC
  • Carmine Jabri, EMMA International
  • Amanda Johnston, Gardner Law, PLLC
  • John D. Kendzior, Reed Smith LLP
  • Geoffrey Levitt, DLA Piper LLP (US)
  • Brian J. Malkin, McDermott Will & Emery
  • Davina R. Marano, FDA – CDRH
  • Christina Anderson Mooney, Medtronic
  • Andrew Papas, NSF International
  • Joseph Pham, FDA-CDER 
  • Schevon Gaylord Salmon, Otsuka America Pharmaceutical, Inc.
  • Kathleen M. Sanzo, Morgan, Lewis & Bockius LLP
  • Juan Serrano, Sanchez Devanny
  • Lance L. Shea, BakerHostetler
  • Eva Temkin, King & Spalding LLP

Tobacco and Nicotine Products Committee ensures that tobacco programs bring diverse stakeholders together to have high-level discussions on tobacco products regulation and policy.

  • Steven Leslie (Staff Liaison), FDLI
  • Jasjit Ahluwalia, Brown University
  • Lindsay Andrews, JUUL Labs
  • Aruni Bhatnagar, University of Louisville School of Medicine
  • Clifford E. Douglas, University of Michigan
  • Carolyn Dresler, Action on Smoking & Health
  • Medina Dzaferi, Swedish Match North America
  • Stacey Younger Gagosian, Truth Initiative
  • Joe G. Gitchell, Pinney Associates, Inc.
  • Dennis Henigan, Campaign for Tobacco-Free Kids
  • Eshael Johnson, FDA
  • Amy Madl, Cardno ChemRisk
  • John L Marshall , Altria Client Services LLC
  • Elizabeth Oestreich, Greenleaf Health, Inc.
  • Laura Leigh Oyler, Turning Point Brands, Inc.
  • John Pritchard, 22nd Century Group, Inc.
  • Agustin Rodriguez, Troutman Pepper Hamilton Sanders LLP
  • Henry Roemer, Finger, Roemer, Brown & Mariani LLP
  • Barry Schaevitz, Fox Rothschild LLP
  • Valerie Briggs Solomon, RAI Service Company (RAISC) (Reynolds American Inc.)
  • Jim Solyst, JMS Scientific Engagement
  • Mark J. Vaders, Womble Bond Dickinson (US) LLP
  • Lauren Caroline Tadros Potter (Staff Liaison), FDLI
  • Margitta Dziwenka, GRAS Associates – a Nutrasource Pharmaceutical and Nutraceutical Services company
  • Laura R. Epstein, CVM, FDA
  • Grace Gowda, International Biomedical Regulatory Sciences, University of Georgia
  • Christine M. Humphrey-Antrim, Humphrey & Associates
  • Keith A. Matthews, Wiley LLP
  • Ted Sullivan, Quarles & Brady LLP

Governance Committees

Audit Committee oversees and evaluates the management’s control over financial reporting. This committee is led by and reports to the FDLI Board of Directors.

*This committee is not seeking applications for 2022

  • Hayley Carpenter (Staff Liaison), FDLI
  • Cathy L. Burgess (Chair), Alston & Bird LLP
  • Neil P. Di Spirito, Epstein Becker & Green, PC
  • Jonathan A. Havens, Saul Ewing Arnstein & Lehr LLP
  • Stuart M. Pape, Polsinelli PC

Black Lives Matter Advisory Group advises FDLI on substantive and programmatic issues relevant to diversity, equity, and inclusion with a focus on promoting greater representation of Black professionals in the food and drug law community.

  • Benjamin Butz (Staff Liaison), FDLI
  • Elizabeth “Betsy” Anderson, Anderson & Associates, LLC and Anthony Lee, Blacks in Government (BIG)
  • Oluwaseun (Kemi) Asante, FDA – CDER
  • Kenita Barrow, Otsuka America Pharmaceutical, Inc.
  • L’Tonya Davis, FDA – ORA
  • Kristin M. Kaplan, Shook, Hardy & Bacon LLP
  • Daniel Kracov, Arnold & Porter LLP
  • Sarah Schick, DLA Piper LLP (US)
  • John (Barr) Weiner, FDA – OC

Finance Committee oversees FDLI’s financial affairs, including budget formulation and execution, and investment portfolio management. This committee is led by and reports to the FDLI Board of Directors.

*This committee is not seeking applications for 2022

  • Hayley Carpenter (Staff Liaison), FDLI
  • Frederick R. Ball (Chair), Duane Morris LLP
  • Jeffrey K. Francer, Association for Accessible Medicines
  • Jeffrey N. Gibbs, Hyman, Phelps & McNamara, PC
  • Elizabeth Oestreich, Greenleaf Health, Inc.
  • Peter Pitts, Center for Medicine in the Public Interest
  • Stuart TenHoor, Stuart TenHoor Legal Search

Questions?

[email protected]
202-222-0910